{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:36:06Z","timestamp":1780526166188,"version":"3.54.1"},"reference-count":27,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Nonalcoholic fatty liver disease, particularly in the presence of hepatic fibrosis, is associated with an increased risk of cardiovascular events, including ischemic stroke. However, it is unclear whether hepatic fibrosis is associated with the severity and outcome of acute ischemic stroke. Aim: To evaluate the relationship between hepatic fibrosis and the severity at admission and in-hospital outcome of acute ischemic stroke. Patients and methods: We prospectively studied all patients who were admitted to our department with acute ischemic stroke between September 2010 and February 2018 (n = 1107; 42.1% males, age 79.8 \u00b1 7.2 years). The severity of stroke was assessed at admission with the National Institutes of Health Stroke Scale (NIHSS). Severe stroke was defined as NIHSS \u2265 21. The presence of hepatic fibrosis was evaluated with the Fibrosis-4 index (FIB-4). The outcome was assessed with dependency at discharge (modified Rankin Scale between 2 and 5) and with in-hospital mortality. Results: Patients with severe stroke had a higher FIB-4 index than patients with non-severe stroke (2.7 \u00b1 1.7 and 2.3 \u00b1 1.4, respectively; p &lt; 0.05). Independent risk factors for severe IS were age (relative risk (RR) 1.064, 95% confidence interval (CI) 1.030\u20131.100, p &lt; 0.001), female sex (RR 1.723, 95% CI 1.100\u20132.698, p = 0.012), atrial fibrillation (RR 1.869, 95% CI 1.234\u20132.831, p = 0.002), diastolic blood pressure (DBP) (RR 1.019, 95% CI 1.006\u20131.033, p = 0.001), and the FIB-4 index (RR 1.130, 95% CI 1.007\u20131.268, p = 0.022). At discharge, 64.2% of patients were dependent. The FIB-4 index did not differ between patients who were dependent and those who were independent at the time of discharge (2.3 \u00b1 1.5 and 2.1 \u00b1 1.2, respectively; p = 0.061). During hospitalization, 9.8% of patients died. Patients who died during hospitalization had a higher FIB-4 index than those who were discharged (2.9 \u00b1 1.8 and 2.3 \u00b1 1.4, respectively; p &lt; 0.005). Independent risk factors for in-hospital mortality were DBP (RR 1.022, 95% CI 1.010\u20131.034, p &lt; 0.001), serum glucose levels (RR 1.004, 95% CI 1.001\u20131.007, p = 0.007), serum triglyceride levels (RR 0.993, 95% CI 0.987\u20130.999, p = 0.023), NIHSS (RR 1.120, 95% CI 1.092\u20131.149, p &lt; 0.001), and the FIB-4 index (RR 1.169, 95% CI 1.060\u20131.289, p = 0.002). Conclusions: Hepatic fibrosis, evaluated with the FIB-4 index, appears to be associated with more severe ischemic stroke and might also represent an independent risk factor for in-hospital mortality in patients admitted with acute ischemic stroke.<\/jats:p>","DOI":"10.3390\/jcm11175141","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T01:50:51Z","timestamp":1661997051000},"page":"5141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatic Fibrosis Is a Risk Factor for Greater Severity and Worse Outcome of Acute Ischemic Stroke"],"prefix":"10.3390","volume":"11","author":[{"given":"Eleftheria","family":"Ztriva","sequence":"first","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-0547","authenticated-orcid":false,"given":"Adonis","family":"Protopapas","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Mentizis","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-3029","authenticated-orcid":false,"given":"Anastasios","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Gogou","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kiosi","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-4211","authenticated-orcid":false,"given":"Maria","family":"Kyziroglou","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Minopoulou","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gkounta","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erofili","family":"Papathanasiou","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Cholongitas","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens 11527, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Savopoulos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3172-1594","authenticated-orcid":false,"given":"Konstantinos","family":"Tziomalos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3748\/wjg.v25.i2.163","article-title":"Current status, problems, and perspectives of non-alcoholic fatty liver disease research","volume":"25","author":"Tanaka","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated with Long-term Outcomes of Patients with Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"ref_10","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204\u20131222."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116524","DOI":"10.1016\/j.jns.2019.116524","article-title":"Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke","volume":"407","author":"Parikh","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.18632\/oncotarget.22755","article-title":"Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: A meta-analysis","volume":"9","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2017.02.005","article-title":"Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke","volume":"260","author":"Kim","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2020.02.020","article-title":"Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?","volume":"158","author":"Gehrke","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fneur.2019.00375","article-title":"The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke","volume":"10","author":"Baik","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_18","first-page":"17562864211037239","article-title":"Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke","volume":"14","author":"Stauber","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000510436","article-title":"Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack","volume":"49","author":"Baik","year":"2020","journal-title":"Cerebrovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2018.05.030","article-title":"Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke","volume":"274","author":"Tziomalos","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/STR.0000000000000086","article-title":"Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Demaerschalk","year":"2016","journal-title":"Stroke"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3389\/fneur.2020.00867","article-title":"Liver Fibrosis Is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jacl.2017.04.115","article-title":"Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome","volume":"11","author":"Abdeldyem","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"577-e34","DOI":"10.1111\/ene.13556","article-title":"Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions","volume":"25","author":"Li","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fahey, M., Crayton, E., Wolfe, C., and Douiri, A. (2018). Clinical prediction models for mortality and functional outcome following ischemic stroke: A systematic review and meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0185402"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000497069","article-title":"Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients","volume":"47","author":"Baik","year":"2019","journal-title":"Cerebrovasc. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:21:03Z","timestamp":1760142063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":27,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jcm11175141"],"URL":"https:\/\/doi.org\/10.3390\/jcm11175141","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]}}}